Newron Pharmaceuticals
NWRN.SW
#8334
Rank
C$0.24 B
Marketcap
$11.95
Share price
-0.70%
Change (1 day)
4.45%
Change (1 year)

EPS for Newron Pharmaceuticals (NWRN.SW)

EPS in 2023: -$1.50

According to Newron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$1.50. In 2023 the company made an earnings per share (EPS) of -$1.50 a decrease over its 2022 EPS that were of -$1.47.

EPS history for Newron Pharmaceuticals from 2005 to 2023

Annual EPS

Year EPS Change
2023-$1.502.03%
2022-$1.4715.39%
2021-$1.28-31.32%
2020-$1.8614.74%
2019-$1.6236.6%
2018-$1.19159.87%
2017-$0.46-67.81%
2016-$1.42-39.24%
2015-$2.33107.61%
2014-$1.1215.8%
2013-$0.97119.91%
2012-$0.44-66.51%
2011-$1.32-71.49%
2010-$4.62-10.83%
2009-$5.1842.06%
2008-$3.6556.53%
2007-$2.33-52.84%
2006-$4.94-188.53%
2005$5.58